Decoy Therapeutics Inc. · NASDAQ:DCOY
Rosenblum Mark J received 9,682 Decoy Therapeutics Inc. shares as an award (Form 4)
Traded Aug 31, 2026 · Filed Sep 2, 2026
On Aug 31, 2026, Rosenblum Mark J (Chief Financial Officer) received 9,682 Decoy Therapeutics Inc. shares as an award, leaving 11,363 shares. Filed Sep 2, 2026 (Form 4).
- Awarded
- 9,682 shares
- Holding after
- 11,363 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Award | 9,682 | 11,363 | Direct |